Register now – Nov. 19, 2025: Regulatory compliance and recent policy changes at the federal and state levels relevant to hospital laboratory outreach programs.

Launch or refresh your lab newsletter with five key steps to engage, inform, and build stronger connections with your audience.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss recent news about the use of artificial intelligence (AI) tools in healthcare.

This week's research roundup features a study on the prognostic role of MYC structural variants identified by NGS and FISH in multiple myeloma.

Top highlights include: Changes to outpatient visitor restrictions in Rochester, MN, Mayo Clinic Q&A podcast on the COVID-19 delta variant, and respiratory illnesses on the rise with symptoms similar to COVID-19.

Top highlights include: a third dose of COVID-19 vaccine sparking debate over booster shots, rare reactions with the J&J COVID-19 vaccine, and can vaccinated people get long Covid.

In this episode, Dr. Morice and Dr. Pritt, discuss the rise in cases of COVID-19 caused by the coronavirus delta variant in the U.S., especially in areas with low vaccination rates.

In May and June 2021, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

Mayo Clinic renal pathologist Dr. Sanjeev Sethi identified NELL-1 as a biomarker for membranous nephropathy (MN) in 2019. Two years later, Dr. Sethi helped implement the first ever IHC test to detect NELL-1 antigen, which appears in about 10% of MN patients and is linked to underlying malignancy.

This week’s research roundup features a study on acute treatments for episodic migraine in adults: A systematic review and meta-analysis.

Topic includes: new vaccine platform invented by Mayo enters COVID-19 clinical trial, Q&A on vaccination and precautions and the new work-life balancing act.

Mayo Clinic’s Advanced Diagnostics Laboratory (ADL) is a visionary space designed to foster innovation. The ADL has a direct impact on patient lives, bringing promising tests and services to patients at Mayo and around the world.

Today's topics feature: Pfizer seeking approval for 3rd vaccine, Minneapolis Fed mandating employees to be vaccinated, U.S. medical stockpile low due to delta variant, shortage of blood donors, COVID-19 vaccine enters clinical trial, and 3 things you can do to improve your heart.

In this episode of Lab Medicine Rounds, Hilary Ryder, M.D., an American Society of Bioethics and Humanities Certified Health Care Ethicist, member of the ethics committee at Texas Health Fort Worth, and former chair of the ethics committee at Dartmouth-Hitchcock Medical Center, discusses medical ethics.

Shawn Mitchell brings a wealth of laboratory expertise to his role as a senior product manager at Mayo Clinic Laboratories, where he puts his knowledge to work promoting Mayo’s innovative infectious disease testing.